Advertisement

Topics

Cormedix, Inc.: CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor

16:21 EST 9 Nov 2017 | FinanzNachrichten

BERKELEY HEIGHTS, NJ / ACCESSWIRE / November 9, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the preven...

Original Article: Cormedix, Inc.: CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor

NEXT ARTICLE

More From BioPortfolio on "Cormedix, Inc.: CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...